Melanoma drug shrinks brain metastases in phase I/II study

A new drug being developed to treat potentially deadly melanoma skin cancers has shown a promising ability to shrink secondary tumours, known as metastases, in the brain in patients with advanced forms of the disease, Australian researchers report...

Read the whole article on

More from